跳至主要内容
临床试验/NCT01568944
NCT01568944已完成不适用

Peripheral Blood Dendritic Cells and Periodontitis

Augusta University1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
Frequency of Blood Dendritic Cells From Baseline

研究概览

简要总结

The investigators hypothesize that blood dendritic cells harbor pathogens from the oral cavity in chronic periodontitis and disseminate these pathogens to atherosclerotic plaques.

详细描述

To address this hypothesis, a clinical study in humans with moderate to severe chronic periodontitis has been designed. This is an interventional study involving scaling and root planing and two arms: 1. treatment with PO amoxocillin/metronidazole plus chlorhexidine oral rinse; 2. no antibiotics or oral rinse. It is expected that the antibiotics plus chlorhexidine will prevent the dendritic cell response to infection (bacteremia) elicited by scaling and root planing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Care Provider)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • generalized moderate to severe chronic periodontitis

排除标准

  • antibiotics treatment within 3 months
  • treatment with steroids, phenytoin, cyclosporin, coumadin
  • presence of conditions requiring prophylactic antibiotics per AHA
  • cancer, HIV, hepB, lupus, prediagnosed heart disease, renal disease

研究组 & 干预措施

Oral Antibiotic and Oral Rinse

Experimental

Each subject will received oral Amoxicillin/Amoxil/lansoprazole/Flagyl 250 mg of each three times a day for 8 days. Subjects will also rinse their mouths with 2 ounces of 0.12% chlorhexidine/peridex mouthrinse two times per day. Subjects will also receive mechanical debridement at the baseline visit. Intervention Amoxicillin/Amoxil/lansoprazol 500 mg/ Metronidazole/Flagyl 250 mg

干预措施: Oral Antibiotic and Oral Rinse (Drug)

Oral Antibiotic and Oral Rinse

Experimental

Each subject will received oral Amoxicillin/Amoxil/lansoprazole/Flagyl 250 mg of each three times a day for 8 days. Subjects will also rinse their mouths with 2 ounces of 0.12% chlorhexidine/peridex mouthrinse two times per day. Subjects will also receive mechanical debridement at the baseline visit. Intervention Amoxicillin/Amoxil/lansoprazol 500 mg/ Metronidazole/Flagyl 250 mg

干预措施: Standard Treatment (Procedure)

Standard Treatment

Other

Subjects assigned to standard treatment will receive full mouth scaling and root planing using hand instrumentation (curettes) and ultrasonic scalers

干预措施: Standard Treatment (Procedure)

结局指标

主要结局

Frequency of Blood Dendritic Cells From Baseline

时间窗: 30 days

The frequency of blood dendritic cells, i.e. % CCR6+CD1a+ DCs by flow cytometry 30 days after treatment with 7 day regimen of antibiotics, mouthrinse therapy and scaling and root planing (SRP) will be compared to those who did not receive the antibiotics, but did receive mouthrinse and scaling and root planing (SRP)

次要结局

  • Serum Cytokine Response(30 days)
  • Probing Attachment Levels(30 days)
  • Probing Depths(30 days)
  • Plaque Index(30 days)
  • Gingival Index(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Cutler

Assoc. Dean Dental Medicine, Dept. Chair Periodontics

Augusta University

研究点 (1)

Loading locations...

相似试验